Richard A. Young - Apr 6, 2023 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Richard A. Young, Ph.D.
Stock symbol
OMGA
Transactions as of
Apr 6, 2023
Transactions value $
-$40,000
Form type
4
Date filed
4/10/2023, 04:05 PM
Previous filing
Mar 20, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMGA Common Stock Sale -$40K -5K -0.66% $8.00 749K Apr 6, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022.